ActiViews, a company involved in development of surgical navigation solutions, said China's State Food and Drug Administration (SFDA) has granted clearance to market CT-Guide navigation for minimal invasive interventions.

The needle guidance system is designed to assist physicians during CT-guided interventional diagnostic and therapeutic procedures, such as percutaneous biopsies, ablations, and marker placements in the lung and liver.

Physicians using the navigation system can have the real-time location of their interventional instruments and the trajectory to target on the CT images.

ActiViews president Christopher von Jako said this registration clearance is a significant accomplishment for ActiViews and supports the global clinical strategy to penetrate markets that are accepting of novel minimal invasive technologies.

"It connects us more closely to Chinese physicians wanting to utilize clinically relevant devices that strive to improve their patients’ health and wellness. We are excited to begin working with Chinese healthcare professionals later this year," Jako added.